Nguyen Thi-Huong, Ko Huey-Jiun, Tsai Po-Yu, Cheng Tai-Shan, Tran Thu-Ha, Doan Ly Hien, Hsiao Michael, Chang Peter Mu-Hsin, Liu Hsiao-Sheng, Hong Yi-Ren, Huang Chi-Ying F., 2024, “Dehydroepiandrosterone Suppresses Human Colorectal Cancer Progression through ER Stress-mediated Autophagy and Apoptosis in A p53-independent Manner”, FRONTIERS IN PHARMACOLOGY, 15, 1464647. (SCIE)
Ho Chiu-Yi, Lin Yu-Te, Sun Gwo-Ching, Wong Tzyy-Yue, Hsiao Michael, Tseng Ching-Jiunn, Cheng Pei-Wen, 2024, “Targeting Acetylated HMGB1 and TLR4 Interaction to Alleviate Hypertension and Neuroinflammation in Fructose-Fed Rats”, BRITISH JOURNAL OF PHARMACOLOGY, 1, 1. (SCIE)
Hsu Tzu-Hui, Chang Yu-Chan, Lee Yi-Yuan, Chen Chi-Long, Hsiao Michael, Lin Fan-Ru, Chen Li-Han, Lin Chun-Hung, Angata Takashi, Liu Fu-Tong, Lin Kuo-I, 2024, “B4GALT1-dependent Galectin-8 Binding with TGF-β Receptor Suppresses Colorectal Cancer Progression and Metastasis”, CELL DEATH & DISEASE, 15(9), 654. (SCIE) (IF: 9; SCI ranking: 16.2%)
Yang Yi-Chieh, Ho Ko-Hao, Pan Ke-Fan, Hua Kuo-Tai, Tung Min-Che, Ku Chia-Chi, Chen Ji-Qing, Hsiao Michael, Chen Chi-Long, Lee Wei-Jiunn, Chien Ming-Hsien, 2024, “ESM1 Facilitates the EGFR/HER3-triggered Epithelial-to-mesenchymal Transition and Progression of Gastric Cancer via Modulating Interplay Between Akt and Angiopoietin-2 Signaling”, INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 20(12), 4819-4837. (SCIE)
Tsui Ke Hung, Liu Chien-Liang, Yeh Hsiu-Lien, Liu Ming-Kun, Li Chien-Hsiu, Chen Wei-Hao, Jiang Kuo-Ching, Li Han-Ru, Dung Phan Vu Thuy, Hsiao Michael, Abou-Kheir Wassim, Liu Yen-Nien*, 2024, “WISP1 Activation through CXCL5/CXCR2/LIF/LIFR Signaling Promotes Immunosuppression and Neuroendocrine Differentiation in Prostate Cancer”, iSCIENCE, 1, 1. (SCIE)
Liu Yen-Nien, Chen Wei-Yu, Yeh Hsiu-Lien, Chen Wei-Hao, Jiang Kuo-Ching, Li Han-Ru, Dung Phan Vu Thuy, Chen Zi-Qing, Lee Wei-Jiunn, Hsiao Michael, Huang Jiaoti, Wen Yu-Ching, 2024, “MCTP1 Increases the Malignancy of Androgen-deprived Prostate Cancer Cells by Inducing Neuroendocrine Differentiation and EMT”, SCIENCE SIGNALING, 17(840), 1. (SCIE)
Lin Wen-Der, Chang Chia-Hao, Pan Jhih-Kai, Lin Forn-Chia, Chen Yu-Chia, Chen Ya-Jyun, Wang Po-Shun, Hong Wei-Qiao, Chen Sheng-Yuan, Lin Cheng-Han, Kuo Yao-Lung, Chung Wei-Pang, Cheng Hui-Chuan, Hsiao Michael, Yang Chia-Ning, Lu Pei-Jung, 2024, “A Novel Long Non-coding RNA MIR4500HG003 Promotes Tumor Metastasis through miR-483-3p-MMP9 Axis in Triple-negative Breast Cancer”, CELL DEATH & DISEASE, 15(5), 310. (SCIE) (IF: 9; SCI ranking: 16.2%)
Chuang Cheng-Hao, Zhen Yen-Yi, Ma Juei-Yang, Lee Tai-Huang, Huang Huei-Yang, Wu Chun-Chieh, Wang Pei-Hui, Huang Ching-Tang, Huang Ming-Shyan, Hsiao Michael, Lee Ying-Ray, Chang Yu-Chan, Huang Chi-Ying F., Yang Chih-Jen, 2024, “CD47 Mediated Immune Evasion in Early Stage Lung Cancer Progression”, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, In Press, 1. (SCIE)
Chan Ming-Hsien, Lee Chi-Yu, Li Chien-Hsiu, Chang Yu-Chan, Wei Da-Hua, Hsiao Michael*, 2024, “Magnetically Guided Theranostics: Novel Nanotubular MRI Contrast System Using Halloysite Nanotubes Embedded with Iron-Platinum Nanoparticles for Hepatocellular Carcinoma Treatment”, SMALL STRUCTURES, In Press, I. (SCIE)
Thirumurugan Senthilkumar, Muthiah Kayalvizhi-Samuvel, Lin Yu-Chien, Dhawan Udeash, Liu Wai-Ching, Wang An-Ni, Liu Xinke, Hsiao Michael, Tseng Ching-Li, Chung Ren-Jei, 2024, “NIR-Responsive Methotrexate-Modified Iron Selenide Nanorods for Synergistic Magnetic Hyperthermic, Photothermal, and Chemodynamic Therapy”, ACS APPLIED MATERIALS & INTERFACES, In Press, 1. (SCIE)
Chang Yu-Chan, Chan Ming-Hsien, Li Chien-Hsiu, Chen Chi-Long, Tsai Wen-Chiuan, Hsiao Michael, 2024, “PPAR-γ Agonists Reactivate the ALDOC-NR2F1 Axis to Enhance Sensitivity to Temozolomide and Suppress Glioblastoma Progression”, CELL COMMUNICATION AND SIGNALING, In Press, 1. (SCIE)
Lin Ying-Chu, Wuputra Kenly, Kato Kohsuke, Ku Chia-Chen, Saito Shigeo, Noguchi Michiya, Nakamura Yukio, Hsiao Michael, Lin Chang-Shen, Wu Deng-Chyang, Kawaguchi Atsushi, Yu Hsin-Su, Yokoyama Kazunari K, 2024, “Di-n-butyl Phthalate Promotes the Neural Differentiation of Mouse Embryonic Stem Cells through Neurogenic Differentiation 1”, ENVIRONMENTAL POLLUTION, Apr 15:347, 123722. (SCIE)
Thirumurugan Senthilkumar, Ramanathan Susaritha, Muthiah Kayalvizhi-Samuvel, Lin Yu-Chien, Hsiao Michael, Dhawan Udesh, Wang An-Ni, Liu Wai-Ching, Liu Xinke, Liao Mei-Yi, Chung Ren-Jei, 2024, “Inorganic Nanoparticles for Photothermal Treatment of Cancer”, JOURNAL OF MATERIALS CHEMISTRY B, 12(15), 3569-3593. (SCIE) (IF: 7; SCI ranking: 21.3%)
Wu Chin-Jui, Pan Ke-Fan, Chen Ji-Qing, Tao Yu -Chen, Liu Yu-Cheng, Chen Bo-Rong, Hsu Ching, Wang Ming-Yang, Sheu Bor-Ching, Hsiao Michael, Hua Kuo-Tai, Wei Lin-Hung, 2024, “Loss of LECT2 Promotes Ovarian Cancer Progression by Inducing Cancer Invasiveness and Facilitating An Immunosuppressive Environment”, ONCOGENE, Feb 9:43(7), 511-523. (SCIE)
Chang Yu‐Chan, Yang Yi‐Fang, Li Chien‐Hsiu, Chan Ming‐Hsien, Lu Meng‐Lun, Chen Ming‐Huang, Chen Chi‐Long, Hsiao Michael*, 2024, “RAB31 Drives Extracellular Vesicle Fusion and Cancer‐associated Fibroblast Formation Leading to Oxaliplatin Resistance in Colorectal Cancer”, JOURNAL OF EXTRACELLULAR BIOLOGY, Feb 23:3(2), 1. (SCIE)
Ngo Loan-Thi, Huang Wen‐Tse, Chan Ming‐Hsien, Su Ting‐Yi, Li Chien‐Hsiu, Hsiao Michael*, Liu Ru‐Shi, 2024, “Comprehensive Neurotoxicity of Lead Halide Perovskite Nanocrystals in Nematode Caenorhabditis elegans”, SMALL, Jan:20(2), e2306020. (SCIE)
Chien Ming-Hsien, Yang Yi-Chieh, Ho Kuo-Hao, Ding Yi-Fang, Chen Li-Hsin, Chiu Wen-Kuan, Chen Ji-Qing, Tung Min-Che, Hsiao Michael, Lee Wei-Jiunn, 2024, “Cyclic Increase in the ADAMTS1-L1CAM-EGFR Axis Promotes the EMT and Cervical Lymph Node Metastasis of Oral Squamous Cell Carcinoma”, CELL DEATH & DISEASE, 15(1), 82. (SCIE)
Ho Chiu-Yi, Sun Gwo-Ching, Lin Yu-Te, Wong Tzyy-Yue, Hsiao Michael, Tseng Ching-Jiunn, Cheng Pei-Wen, 2024, “Microglial Activation and Toll-like Receptor 4-Dependent Regulation of Angiotensin II Type I Receptor-mu-opioid Receptor 1 Heterodimerization and Hypertension in Fructose-fed Rats”, EUROPEAN JOURNAL OF PHARMACOLOGY, Jan5:962, 176171. (SCIE)
Lin, Kuo-I
Hsu, T.-H., Chang, Y.-C., Lee, Y.-Y., Chen, C.-L., Hsiao, M., Lin, F.-R, Chen, L.-H., Lin, C.-H., Angata, T., Liu, F.-T., and Lin, K.-I*., 2024, “B4GALT1-dependent galectin-8 binding with TGF-β receptor suppresses colorectal cancer progression and metastasis”, Cell Death and Disease, 15(9):, 654. (SCIE) (IF: 9; SCI ranking: 16.2%)
Chou, S.-C., Yen, C.-T., Yang, Y.-L., Chen, S.-H., Wang, J.-D., Fan, M.-N., Chen, L.-F., Yu, I-S., Tsai, D.-Y., Lin, K.-I, Tao, M.-H., Wu, J.-C., and Lin, S.-W., 2024, “Recapitulating the immune system of hemophilia A patients with inhibitors using immunodeficient mice”, Thrombosis Research, 235, 155-163. (SCIE)
Huang, C.-H., Yang, T.-T. and Lin, K.-I*., 2024, “Mechanisms and functions of SUMOylation in health and disease: a review focusing on immune cells”, J Biomed Sci., 31(1), 16. (SCIE)
Shen, Chia-Ning
Chang PS, Chen YC, Hua WK, Hsu JC, Tsai JC, Huang YW, Kao YH, Wu PH, Wang PN, Chang YF, Chang MC, Chang YC, Jian SL, Lai JS, Lai MT, Yang WC, Shen CN, Wen KK, Wu SC, 2024, “Manufacturing CD20/CD19-targeted iCasp9 regulatable CAR-TSCM cells using a Quantum pBac-based CAR-T engineering system.”, PloS one, 19(8), e0309245. (SCIE)
Panda SS, Lee CC, Geevimaan K, Chen KC, Yang SH, Shen CN, HuangFu WC, Wu HC, 2024, “Intracellular domain of epithelial cell adhesion molecule induces Wnt receptor transcription to promote colorectal cancer progression.”, Journal of biomedical science, 31(1), 72. (SCIE) (IF: 11; SCI ranking: 14.1%,9.6%)
Huang, Y.K., W.C. Cheng, J.C. Yang, Y.C. Wu, H.H. Wu, T.T. Kuo, C.C. Lo, C.Y. Hsieh, S.C. Wong, C.H. Lu, C.N. Shen, M.C. Hung, J.T. Lin, C.C. Yeh, Y.P. Sher., 2024, “Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy”, Nature Cancer, 5(3), 400-419. (SCIE)
Yang, Hwai-I
Lee MH, Chen YT, Huang YH, Lu SN, Yang TH, Huang JF, Yin SC, Yeh ML, Huang CF, Dai CY, Chuang WL, Yu ML, Yang HI, Chen HY, Chen CJ, 2024, “Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCC.”, CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, S1542-3565(24)00198-8, doi: 10.1016/j.cgh.2024.01.045. (SCIE)
Teng W, Chang TT, Yang HI, Peng CY, Su CW, Su TH, Hu TH, Yu ML, Yang HC, Wu JC, 2024, “Correction to: Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines.”, HEPATOLOGY INTERNATIONAL, 18(3), 1066. (SCIE)
Lin HC, Jeng WJ, Yang HI*, 2024, “Editorial: High qHBsAg-Is it a good or bad signal? Authors' reply.”, ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 59(12), 1618-1619. (SCIE)
Lin HC, Jeng WJ, Yang HI*, 2024, “Letter: Association of persistently high HBsAg levels during HBeAg-seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients-Authors' reply.”, ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 59(11), 1459-1461. (SCIE)
Shen HC, Pan MH, Huang CJ, Yeh HY, Yang HI*, Lin YH, Huang CC, Lee KC, Yang YY, Hou MC, 2024, “Multiple genetic polymorphisms are associated with the risk of metabolic syndrome, fatty liver, and airflow limitation: A Taiwan Biobank study.”, GENE, 927, 148660. (SCIE)
Lin HC, Jeng WJ, Liu J, Pan MH, Lee MH, Batrla-Utermann R, Lu SN, Chen CF, Yang HI*, Chen CJ, 2024, “Persistently high HBsAg levels during HBeAg-seropositive stage predict lower risk of hepatocellular carcinoma in chronic hepatitis B patients.”, ALIMENTARY PHARMACOLOGY & THERAPEUTICS, doi: 10.1111/apt.17915, Online ahead of print. (SCIE)
Chen YJ, Hsiao TH, Lin YC, Jeng WJ, Mao CL, Wei CY, Hsieh YC, Huang CJ, Pan MH, Chen IC, Lin CH, Chen YM, Yang HI*, 2024, “Polygenic Risk Score Predicts Earlier-Onset Adult Systemic Lupus Erythematosus and First-Year Renal Diseases in a Taiwanese Cohort.”, RMD OPEN, 10(2), e003293. (SCIE)
Lin HC, Jeng WJ, Yang HI*, 2024, “Response to Chen and Liaw.”, CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 15(3), e00663. (SCIE)